Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model

BACKGROUND: Tuberculosis (TB) is one of the most prevalent cause of death due to a single pathogen. Bacillus Calmette Guérin (BCG) is the only vaccine available for clinical use that protects against miliary TB; however, this vaccine has shown variable levels of efficacy against pulmonary TB. In Ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashyap, Rajpal S, Husain, Aliabbas A, Morey, Shweta H, Panchbhai, Milind S, Deshpande, Poonam S, Purohit, Hemant J, Taori, Girdhar M, Daginawala, Hatim F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890520/
https://www.ncbi.nlm.nih.gov/pubmed/20509931
http://dx.doi.org/10.1186/1476-8518-8-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890520/
https://www.ncbi.nlm.nih.gov/pubmed/20509931
http://dx.doi.org/10.1186/1476-8518-8-3

Ejemplares similares